Sources | Names Used |
---|---|
CTRPv2 | compound 1B |
PharmacoGx | compound 1B |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DALRD3 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
mRNA | LGALS3BP | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
mRNA | POLL | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
mRNA | ABHD13 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
mRNA | CASC4 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
mRNA | RHAG | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
mRNA | IMPAD1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
mRNA | EXOSC2 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
mRNA | ZNF550 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
mRNA | DNMT3B | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |